This study is aimed at identifying genetic variants that influence susceptibility to migraine. We plan to use DNA samples already collected from families with multiple migraine affected individuals and sequence a region on the X chromosome that has previously been identified as harbouring a migraine susceptibility gene. This project will identify gene(s) that contain variants contributing to migraine.
High Resolution Mapping Of Genomic Regions Implicated In Migraine
Funder
National Health and Medical Research Council
Funding Amount
$392,545.00
Summary
Migraine is a frequent, debilitating and painful disorder that affects a significant proportion of the population. Using the diagnostic criteria of the international Headache Society, the prevalence of migraine has been estimated to be approximately 12%, with a recent study in the United States showing that migraine affects 4% of children, 6% of men and 18% of women. The aetiology of migraine is unknown and there are no laboratory based diagnostic tests to identify those who suffer from the diso ....Migraine is a frequent, debilitating and painful disorder that affects a significant proportion of the population. Using the diagnostic criteria of the international Headache Society, the prevalence of migraine has been estimated to be approximately 12%, with a recent study in the United States showing that migraine affects 4% of children, 6% of men and 18% of women. The aetiology of migraine is unknown and there are no laboratory based diagnostic tests to identify those who suffer from the disorder. Clinical diagnosis is currently based on patient symptom descriptions, with individual symptoms being shown to vary with age. Migraine is believed to have a genetic basis with specific environmental factors, such as particular foods, hormonal levels and fatigue, being capable of inducing attacks in predisposed individuals. Migraine shows strong familial aggregation with about 50% of those affected, having another close relative also affected with the disorder. At present the number of genes involved in the disorder is unknown and have not been identified. Recent studies in our laboratory have localised two migraine genes, one to chromosome 19 and the other to the X chromosome. More recently we have also found evidence for a third gene on chromosome 1. This study is aimed at fine scale mapping analysis of these three chromosomal regions in order to pinpoint the location of migraine genes. Our ultimate aim is to identify the molecular causes of this disorder. This would have important implications to both the diagnosis and treatment of migraine.Read moreRead less
Identification And Characterisation Of Phenotypic Modifier Genes In Familial Alzheimer's Disease
Funder
National Health and Medical Research Council
Funding Amount
$413,250.00
Summary
Alzheimer's disease (AD) is the most common cause of dementia the fourth most common cause of death. There are no effective cures for AD and those drugs currently available are of very limited value in delaying the onset and progression of this invariably fatal disease. AD is diagnosed by two key features in the brain, dense plaques composed of the amyloid beta peptide, and tangles composed of the tau protein. The identification of new therapeutic targets, such as the enzymes which produce amylo ....Alzheimer's disease (AD) is the most common cause of dementia the fourth most common cause of death. There are no effective cures for AD and those drugs currently available are of very limited value in delaying the onset and progression of this invariably fatal disease. AD is diagnosed by two key features in the brain, dense plaques composed of the amyloid beta peptide, and tangles composed of the tau protein. The identification of new therapeutic targets, such as the enzymes which produce amyloid beta peptide, and the development of drugs that interact with these targets offers the prospect of developing treatments to delay disease onset, retard or even halt the development of this relentlessly progressive disease. Our research focuses on the genes that are involved in variant forms of AD. One neuropathological variant form we and others have described is characterised by large diffuse (cotton wool) amyloid plaques. Cotton wool plaque pathology is associated with AD causing mutations in the presenilin 1 (PS-1) gene. Another clinical AD variant that we have described is characterised by the presence of spastic paraparesis (SP). SP is associated with PS-1 mutations, but when present delays disease onset. We have identified two potential modifier genes which are likely to be directly involved in the production of cotton wool plaques or modifying the effect of PS-1 mutations and the occurence of SP. For both genes, the goal of this project is to use a range of genetic approaches to clone the modifier genes by and to assess their effects on the clinical and pathological development of AD. By studying the effects of genes which act to modify the effects of the PS-1 mutations in these variant forms of AD we hope to gain a greater understanding of how the plaques and tangles actually lead to the clinical symptoms of the disease and to gain insights into new ways in which AD may be treated.Read moreRead less
Identifying Rare Genetic Variants Conferring Susceptibility To Multiple Sclerosis
Funder
National Health and Medical Research Council
Funding Amount
$293,898.00
Summary
Recently there has been success in identifying common genetic variants that confer susceptibility to multiple sclerosis. The variants that have been discovered so far have modest effects on risk of disease, and only explain a small proportion of familial aggregation of disease. In this study we aim to identify rarer genetic variants that have stronger effects on risk of disease, using new statistical methods and new methods to sequence very large amounts of DNA.
Molecular Genetics Of Dyslexia: A Component Processes Approach
Funder
National Health and Medical Research Council
Funding Amount
$348,960.00
Summary
With the advent of the human genome project, Australian researchers into serious childhood reading disorders are now in a position to make breakthroughs in understanding the complex linkages between genes and dyslexia. It is widely acknowledged that previous studies on the genetics of dyslexia have been limited by their failure to distinguish the different component processes in reading and the different patterns of dyslexia that they produce, and by being unable to look widely across the human ....With the advent of the human genome project, Australian researchers into serious childhood reading disorders are now in a position to make breakthroughs in understanding the complex linkages between genes and dyslexia. It is widely acknowledged that previous studies on the genetics of dyslexia have been limited by their failure to distinguish the different component processes in reading and the different patterns of dyslexia that they produce, and by being unable to look widely across the human genome. This new research addresses these two problems. Firstly, the researchers have developed a computational model of reading that identifies around a dozen basic mental processes which are recruited during skilled reading. This model provides the extremely precise phenotypes required for genetic research. Secondly, the researchers will take advantage of both very high density scans within known regions of interest on chromosomes 2,6, and 15, as well as a genome-wide scan of 400 markers small elements of DNA whose position within the genome is known, thus allowing researchers to narrow-down the location of new genes for reading. The research thus promises not only to refine our understanding of the basis for three previous genetic markers of dyslexia, but also to potentially uncover new genes related to specific elements of reading across the genome. The project pools the resources of the Macquarie Centre for Cognitive Science, the Australian Genome Research Facility, and The Garvan Institute and the researchers hope that the work will lead eventually to identifying the genes for dyslexia and to improved diagnosis and treatment of reading disorders in Australia.Read moreRead less
Chronic or extreme reactions to stress can lead to pathological conditions such as long term anxiety states, depression and panic disorders. Stress related disease also contributes to other major health problems such as heart disease and disorders of the immune system. These disease states include some of the major medical problems of our times. This proposal is to define genes which may be involved in stress responsiveness, to further understand and treat stress related disease.
Molecular Genetics Of Hereditary Motor And Sensory Neuropathy With Pyramidal Signs
Funder
National Health and Medical Research Council
Funding Amount
$235,500.00
Summary
This project aims to determine the molecular cause of hereditary motor neuropathies with pyramidal signs by chromosomal linkage studies and to screen suitable families to locate genes with disease causing mutations. We propose to use the resources of the human genome project to locate the defective gene. In previous studies we have used these methods to identify genes of two other hereditary diseases of nerve. Our data suggests that this disorder forms part of the largest group of hereditary neu ....This project aims to determine the molecular cause of hereditary motor neuropathies with pyramidal signs by chromosomal linkage studies and to screen suitable families to locate genes with disease causing mutations. We propose to use the resources of the human genome project to locate the defective gene. In previous studies we have used these methods to identify genes of two other hereditary diseases of nerve. Our data suggests that this disorder forms part of the largest group of hereditary neuropathies yet to be defined. Because this disorder affects long spinal cord neurones, identifying the mutated gene and studying its function may shed light on possible mechanisms involved in other spinal cord diseases. This research is a systematic search and should lead to identifying the abnormal gene causing disease. Once the gene involved is known then an effective diagnostic test will be developed. When a test for the disease is available, it is likely that we will find that the disorder is more common than previously recognised. Knowledge of the function of the gene will lead to an understanding of how the disease develops and will eventually enable development of effective treatments.Read moreRead less